ESC in Asia
Expanding the boundaries of cardiovascular medicine with an Asia-Pacific focus
The ESC has developed collaborative relationships with its cardiac society partners in Asia and organises dedicated 'ESC in Asia' tracks together with the Asian Pacific Society of Cardiology (APSC) and Asean Federation of Cardiology (AFC).
We aim to make a difference in the prevention, diagnosis and management of cardiovascular disease on a global scale. To do this, it is extremely important that we:
- Exchange for a better understanding of the regional needs and to share the latest worldwide science for best practice to advance the battle against cardiovascular disease.
- Collaborate with partners to strengthen connections between Asia Pacific cardiovascular professionals and the global community, including through joint participation in scientific events and initiatives.
ESC in Asia with APSC, 15 and 16 May 2026, Taipei-Taiwan
The European Society of Cardiology is presenting a track at the Asian Society of Cardiology Congress, taking place in Taipei-Taiwan at the Taipei International Convention Centre.
The two renowned cardiovascular societies bring together the latest in cutting-edge cardiovascular science with an Asia-Pacific focus.
Special ESC Scientific Track at APSC 2026
Focus on Latest ESC Guidelines & Hotlines
This programme is designed to offer cardiologists a comprehensive update on the latest ESC Guidelines for the Management of Valvular Heart Disease, Management of Myocarditis and Pericarditis, Management of Dyslipidaemias, Management of Cardiovascular Disease and Pregnancy and Hot Lines focusing on coronary syndrome in an engaging format. The day will include clinical cases presentation, panel discussions, key messages and audience participation.
Friday, 15 May 2026
15:50-17:10 (80 min) Room 101AD, TICC
Session based on Hot Lines presented at ESC Congress 2025 focusing on coronary syndromes.
Chairpersons:
1 APSC Chairperson: Toshihisa Anzai, Japan
1 ESC Chairperson: Franz Weidinger, Austria
Panelists:
Alan Fong, Malaysia
Tzung-Dau Wang, Taiwan
I-Chang Hsieh, Taiwan
Yoshio Kobayashi, Japan
Huynh Van Minh, Vietnam
• Deep dive presentation of the AQUATIC & DUAL ACS trials – 15 min
Speaker: ESC Representative - Franz Weidinger, Austria
• Panel discussion on how these trials would change the daily practice in Asia-Pacific – 25 min
• Deep dive presentation of the Reboot CNIC & BETAMI DANBLOCK trials – 15 min
These two studies focus on beta blocker therapy after a Myocardial infarction and with an ejection >40%. It should generate a good discussion with the APSC colleagues on which patient should benefit from long-term beta blocker therapy after a myocardial infarction.
Speaker: ESC Representative – Chris Plummer, UK
• Panel discussion on how these trials would change the daily practice in Asia-Pacific – 25 min
Saturday, 16 May 2026
08:30-09:50 (80 min) Room 101AD, TICC
2025 ESC/EACTS Guidelines for the Management of Valvular Heart Disease
2025 ESC Guidelines for the Management of Myocarditis and Pericarditis
Chairpersons:
1 APSC Chairperson - Khung-Keong Yeo, Singapore
1 ESC Chairperson - Karin Klingel, Germany
Panelists:
Khung-Keong Yeo, Singapore
Isman Firdaus, Indonesia
Raj Kumar Sachdewani, Pakistan
Wei-Hsian Yin, Taiwan
Wen-Chung Yu, Taiwan
Topic 1 - 2025 ESC/EACTS Guidelines for the Management of Valvular Heart Disease
• Clinical case presentation – 5 min
Speaker: APSC Representative - Amiliana Soesanto, Indonesia
• Key messages of the 2025 ESC/EACTS Guidelines for the Management of Valvular Heart Disease – 15 min
Speaker: ESC Representative - Gianluca Pontone, Italy
• Panel discussion – Guidelines implementation in Asia-Pacific - 15 min
All Faculty
• Wrap-up - 5 min
Topic 2 - 2025 ESC Guidelines for the Management of Myocarditis and Pericarditis
• Clinical case presentation – 5 min
Speaker: APSC Representative - Yasushi Ueki, Japan
• Key messages of the 2025 ESC Guidelines for the Management of Myocarditis and Pericarditis – 15 min
Speaker: ESC Representative – Karin Klingel, Germany
• Panel discussion – Guidelines implementation in Asia-Pacific - 15 min
All Faculty
• Wrap-up - 5 min
Saturday, 16 May 2026
10:10-11:30 (80 min)
2025 Focused Update of the 2019 ESC/EAS Guidelines for the Management of Dyslipidaemias
2025 ESC Guidelines for the Management of Cardiovascular Disease and Pregnancy
Chairpersons:
1 APSC Chairperson - Junya Ako, Japan
1 ESC Chairperson - Franz Weidinger, Austria
Panelists:
AKM Mohibullah, Bangladesh
Dima Quraini, UAE
Yen-Wen Wu, Taiwan
Wen-Jone Chen, Taiwan
Sungha Park, Korea
Topic 1 - 2025 Focused Update of the 2019 ESC/EAS Guidelines for the Management of Dyslipidaemias
• Clinical case presentation – 5 min
Speaker: APSC Representative - Sanjay Tyagi, India
• Key messages of the 2025 Focused Update of the 2019 ESC/EAS Guidelines for the Management of Dyslipidaemias – 15 min
Speaker: ESC Representative - Franz Weidinger, Austria
• Panel discussion – Guidelines implementation in Asia-Pacific - 15 min
All Faculty
• Wrap-up - 5 min
Topic 2 - 2025 ESC Guidelines for the Management of Cardiovascular Disease and Pregnancy
• Clinical case presentation – 5 min
Speaker: APSC Representative - Geetha Kandavello, Malaysia
• Key messages of the 2025 ESC Guidelines for the Management of Cardiovascular Disease and Pregnancy – 15 min
Speaker: ESC Representative – Chris Plummer, UK
• Panel discussion – Guidelines implementation in Asia-Pacific - 15 min
All Faculty
• Wrap-up - 5 min
Special ESC Scientific Track at AFC 2026
Brunei - 15/18 October 2026
Programme under review
Contact
We will be delighted to welcome you to these events.
In the meantime, send us an email at escasia@escardio.org if you have any questions.